1. IMPROVED AQUEOUS DISSOLUTION OF NIMODIPINE USING SELF-MICROEMULSIFYING SOLID COMPOSITIONS.
- Author
-
YONG HAK LEE, DOHYUN KIM, BYOUNG HYEN KO, YOUNGWOO KIM, MYA THET PAING SOE, YEE YEE TIN, and JAEHWI LEE
- Subjects
AQUEOUS solutions ,NIMODIPINE ,CALCIUM antagonists ,SURFACE active agents ,POLYETHYLENE glycol - Abstract
Nimodipine is a highly lipophilic calcium channel blocker presenting extremely low aqueous solubility. This study aimed to develop solid self-microemulsifying tablets (SSMETs) that can considerably increase the apparent aqueous solubility and dissolution of nimodipine. For the selection of proper components of liquid state self-microemulsifying formulations (LSMEFs), nimodipine solubility and emulsification capability were evaluated. Based on these two factors, Capryol™ 90, Cremophor® EL, and polyethylene glycol 400 (PEG 400) were chosen as oil, surfactant, and co-surfactant, respectively. The optimized LSMEF was then established through the construction of pseudo-ternary phase diagrams. Next, to solidify the optimized LSMEF, several adsorbents were screened, and the LSMEF solidified with Neusilin® UFL2 showed the highest dissolution profile with an appropriate solvent binding capacity. To further facilitate the drug release from the SSMETs, several disintegrants were investigated, and the SSMET containing Primellose® as a disintegrant substantially increased the dissolution of nimodipine. In addition, when the SSMET re-dispersed in simulated intestinal fluid, the SSMET successfully formed microdroplets presenting similar small size (~90 nm) to droplets dispersed from the LSMEF. These results demonstrated that this SSMET we designed is a promising drug delivery system for poorly soluble drugs, such as nimodipine. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF